Home | NRI | Business Associates | Knowledge Bank | Careers | Back Office | Contact Us
 

Get Quotes
Company Background
Board Of Directors
Balance Sheet
Profit & Loss Accounts
Quarterly Results
Key Financial Ratios
Share Price
Charts
 
  
Quarterly Results
Jubilant Pharmova Ltd
    Industry   : Pharmaceuticals - Indian - Bulk Drugs  Chairman  : Shyam S Bhartia
    Home        : Jubilant Bhartia  Book Value: 144.2956685
    BSE Code  : 530019  Market Cap: 13187.65
    NSE Code  : JUBLPHARMA  P / E              : 267.91 

Change Company :
   Quarters: 
(Rs in Cr.)
Quarterly Results
ParticularsDec 2024Sep 2024Jun 2024Mar 2024
Type3Qtr2Qtr1Qtr4Qtr
Net Sales193.40162.60162.70201.70
Other Income18.4043.8019.5050.10
Total Income214.40209.50186.20255.90
Total Expenditure 185.00171.80176.70193.60
Operating Profit29.4037.709.5062.30
Interest7.407.807.608.10
Gross Profit22.0029.901.9054.20
Depreciation13.3013.3013.1012.70
Tax6.305.300.006.80
Deferred Tax-2.900.80-1.002.20
Reported Profit After Tax5.3010.50-10.2032.50
BSE Disclaimer     |     Disclaimer     |     Privacy Statement     |     Terms of Use     |     Feedback     |    Sitemap     |    Downloads    |     Client Bank Details
Useful Links   | Risk Disclosure   | Rules and Regulations   |   Investor Charter   |   Investor Complaints   |   Smart ODR   |   Attention Investors   |

SEBI Saa₹thi Mobile App/SEBI Investor Website  
SSJ FINANCE & SECURITIES PRIVATE LIMITED:
1st Floor, Merchant Chamber, Opp. Patkar Hall, 41, New Marine Lines, Mumbai – 400 020
SEBI Regn. Number: INZ000178436 | CDSL: IN-DP-109-2015 | ARN: 40860 | CIN: U67120MH1996PTC104822
SSJ COMMODITIES PRIVATE LIMITED:
SEBI Regn. Number: INZ000013439 | CIN: U51909MH2003PTC140481|Research Analyst SEBI Reg. No.INH000001527
2006-07 © SSJ Finance & Securities Pvt. Ltd. All Rights Reserved Developed & Maintained By C-MOTS Infotech(ISO 9001:2015 certified)
Content powered by Capital Market Charts are powered by TradingView